L'ospedale Infermi è l'ospedale pubblico della città di Rimini, situato a sud della città, ma non lontano dal centro cittadino.

During the past decade, Ospedale "Infermi" conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 25 clinical trials were completed, i.e. on average, 33.8% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 19 clinical trials were completed. i.e. 86.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale "Infermi"" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 16 trials, followed by "ETOP IBCSG Partners Foundation" with 7 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored and "Bristol-Myers Squibb" with 6 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale "Infermi"" #1 collaborator was "Breast International Group" with 4 trials as a collaborator, "AUSL Romagna Rimini" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale "Infermi"" are "Breast Cancer" (10 trials), "Multiple Myeloma" (6 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Chronic Myeloid Leukemia" (3 trials) and "HIV Infections" (3 trials). Many other conditions were trialed in "Ospedale "Infermi"" in a lesser frequency.

Most popular intervention types in "Ospedale "Infermi"" are "Drug" (87 trials), "Other" (16 trials), "Procedure" (7 trials), "Device" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Cyclophosphamide" (7 trials), "Lenalidomide" (6 trials), "Rituximab" (6 trials) and "Doxorubicin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale "Infermi"" are 105 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 40 active trials in "Ospedale "Infermi"". 1 are not yet recruiting, 15 are recruiting, 23 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 59 completed trials in Ospedale "Infermi", undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale "Infermi", 3 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 8 trials that are defined as “Not Applicable".